GPT and metabolic dysfunction-associated steatotic liver disease: Primary:96-week sustained ALT reduction.Secondary:96-week changes in AST, NAFLD, BMI, QOL scores; liver fibrosis score, steatosis score, lobular inflammation score, ballooning degradation score.